RAB3GAP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.481200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.892600E-01
Normal-vs-Stage2
6.363400E-01
Normal-vs-Stage3
1.170600E-01
Normal-vs-Stage4
8.474800E-01
Stage1-vs-Stage2
6.538400E-01
Stage1-vs-Stage3
1.196800E-01
Stage1-vs-Stage4
7.060200E-01
Stage2-vs-Stage3
1.902440E-01
Stage2-vs-Stage4
3.893800E-01
Stage3-vs-Stage4
1.311360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.974400E-01
Normal-vs-AfricanAmerican
7.907000E-01
Normal-vs-Asian
6.029400E-01
Caucasian-vs-AfricanAmerican
2.484800E-01
Caucasian-vs-Asian
9.629000E-01
AfricanAmerican-vs-Asian
3.086200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.743600E-01
Normal-vs-Female
6.339400E-01
Male-vs-Female
9.018400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.835800E-01
Normal-vs-Age(41-60Yrs)
9.756000E-01
Normal-vs-Age(61-80Yrs)
5.406400E-01
Normal-vs-Age(81-100Yrs)
4.567200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.850200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.128600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.852800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.168400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.912430E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.041400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.320200E-01
Normal-vs-Daily Drinker
1.333750E-01
Normal-vs-Weekly Drinker
6.145600E-01
Normal-vs-Occasional Drinker
8.592000E-01
Normal-vs-Social Drinker
8.634200E-01
Non Drinker-vs-Daily Drinker
1.662250E-01
Non Drinker-vs-Weekly Drinker
6.647800E-01
Non Drinker-vs-Occasional Drinker
2.830300E-02
Non Drinker-vs-Social Drinker
2.217400E-01
Daily Drinker-vs-Weekly Drinker
1.714600E-01
Daily Drinker-vs-Occasional Drinker
2.721900E-03
Daily Drinker-vs-Social Drinker
3.943600E-02
Weekly Drinker-vs-Occasional Drinker
2.193000E-01
Weekly Drinker-vs-Social Drinker
5.775600E-01
Occasional Drinker-vs-Social Drinker
5.350400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.542500E-02
Normal-vs-Grade 2
8.843800E-03
Normal-vs-Grade 3
1.010170E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.712400E-01
Grade 1-vs-Grade 3
2.273800E-01
Grade 1-vs-Grade 4
4.542500E-02
Grade 2-vs-Grade 3
2.152600E-01
Grade 2-vs-Grade 4
8.843800E-03
Grade 3-vs-Grade 4
1.010170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.428600E-01
Normal-vs-NonDiabetic
5.609800E-01
Diabetic-vs-NonDiabetic
1.664820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.059500E-02
Normal-vs-NoPancreatitis
5.681800E-01
Pancreatitis-vs-NoPancreatitis
4.742000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.850200E-01
Normal-vs-N1
5.905000E-01
N0-vs-N1
4.084400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.789400E-01
Normal-vs-TP53-NonMutant
9.586200E-01
TP53-Mutant-vs-TP53-NonMutant
7.898800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
